![](https://endpts.com/wp-content/uploads/2020/07/CureVac-Franz-Werner-Haas-with-German-ministers-AP-Images-endpts-tile-scaled.jpg)
Peter Altmaier (l), Federal Minister of Economics and Technology, and Ulrich Nu'baum (r), State Secretary in the Federal Ministry of Economics, take part in a press conference with Franz-Werner Haas (on screen), CEO of the biotech company Curevac, and the investor Hopp.
GSK, Germany push coronavirus-focused mRNA player CureVac's latest round to $640M
After courting some high-profile investors, CureVac has closed a whopping $640 million (€560 million) in its latest round.
The biotech announced the financing in a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.